Clinical Trial Update: Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of X0002 for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• X0002

Snippet

Sponsor: Jiangsu XinChen-Techfields Pharma Co., LTD. | Conditions: KNEE OSTEOARTHRITIS | Phase 3 | Status: COMPLETED